Latest ADMA reports update at 2024-05-09: 2024-Q12023-Q42023-Q1
ADMA Biologics logo
ADMA Biologics ADMA
$ 6.93 1.02%

ADMA Biologics Financial Ratios 2011-2024 | ADMA

Annual Financial Ratios ADMA Biologics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-42.8 -9.2 -2.7 -2.5 -4.6 -2.2 -2.0 -3.2 -3.5 - -3.6 - -

P/S

4.7 3.9 2.4 4.5 7.6 8.4 3.8 5.8 8.8 - 18.2 - -

EPS

-0.1 -0.3 -0.5 -0.9 -0.9 -1.4 -1.9 -1.6 -1.7 -1.8 -2.4 -1.8 -16.7

EV (Enterprise Value)

1.35 B 717 M 281 M 255 M 296 M 189 M 112 M 80.3 M 75.3 M 571 M 40.1 M -6.4 M -78 K

EBITDA per Share

0.13 -0.17 -0.38 -0.745 -0.747 -1.32 -1.63 -1.39 -1.44 - -2.27 - -

EV/EBITDA

-4.2 -3.6 -6.9 -2.8 -2.3 -4.3 -4.5 - -2.3 - -

PEG

0.66 0.28 0.15 -2.25 -0.12 -0.09 0.11 -0.46 -0.79 - 0.07 - -

P/B

8.9 4.0 1.4 2.2 8.5 7.2 2.2 -13.9 76.5 36.0 2.6 - -

P/CF

137.4 -10.2 -1.8 -1.7 -2.8 -2.2 -2.2 -3.4 -4.1 - -5.0 - -

ROE %

-20.89 -43.37 -50.75 -85.83 -184.32 -332.53 -108.49 437.83 -2188.85 - -71.97 - -

ROA %

-8.58 -18.91 -25.94 -36.47 -37.99 -73.97 -40.51 -82.39 -75.78 - -48.55 - -

ROCE %

16.00 -25.90 -41.35 -34.58 -36.64 -76.07 -39.02 -139.06 -79.57 - -53.11 - -

Current Ratio

1.7 1.8 2.0 7.7 6.1 4.6 6.7 1.9 5.0 7.2 8.5 - -

DSO

30.3 52.2 94.3 114.4 43.2 29.9 62.2 34.9 47.0 - - - -

DIO

362.5 442.4 471.9 485.6 490.3 161.0 158.0 288.1 291.7 - 301.1 - -

DPO

31.1 39.4 53.8 65.9 84.8 51.0 74.1 147.2 176.8 - 488.8 - -

Operating Cycle

392.8 494.6 566.2 600.0 533.4 191.0 220.3 322.9 338.7 - 301.1 - -

Cash Conversion Cycle

361.6 455.2 512.4 534.1 448.7 139.9 146.2 175.8 162.0 - -187.7 - -

All numbers in USD currency

Quarterly Financial Ratios ADMA Biologics

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.08 - 0.01 -0.03 -0.03 - -0.08 -0.07 -0.13 - -0.13 -0.15 -0.16 - -0.19 -0.23 -0.26 - -0.19 -0.25 -0.28 -0.39 -0.33 -0.35 -0.39 - -0.59 -0.55 -0.51 - -0.34 -0.5 -0.43 - -0.48 -0.44 -0.37 - -0.36 -0.43 -0.64 - -0.46 -0.83 -0.55 - -0.55 -0.2 -0.18 - -2.79 - -4.5

EBITDA per Share

0.1 - 0.05 0.01 - - -0.04 -0.04 -0.07 - -0.1 -0.11 -0.12 - -0.15 -0.19 -0.22 - -0.14 -0.2 -0.27 -0.35 -0.28 -0.29 -0.35 - -0.53 -0.49 -0.45 - -0.28 -0.44 -0.38 - -0.42 -0.32 -0.31 - -0.32 -0.38 -0.61 - -0.42 -0.81 -0.53 - -0.54 -0.2 -0.35 - -1.75 -5.12 -3.75

ROE %

10.63 -7.31 -22.15 -38.69 -46.38 -46.58 -63.81 -66.20 -71.11 -50.51 -69.68 -71.62 -77.54 -63.84 -107.51 -132.01 -159.59 -144.00 -235.24 -268.12 -292.28 -332.53 -278.99 -240.13 -187.94 -76.31 20.87 155.73 313.03 335.54 -285.97 -1004.65 -1709.51 -1630.66 -1686.99 -1121.81 -617.76 -220.51 -232.98 -189.11 -145.88 -50.18 -84.62 -106.60 -96.72 -53.59 -55.74 -275.59 -266.28 -669.56 -254.29 -3.50 -409.62

ROA %

4.69 -3.11 -8.07 -13.76 -16.54 -17.71 -25.13 -27.60 -31.08 -23.34 -31.49 -32.21 -33.81 -27.13 -36.13 -36.98 -36.49 -28.50 -48.80 -56.83 -64.20 -73.97 -67.75 -64.79 -56.57 -28.49 -46.78 -50.99 -68.01 -63.15 -84.66 -87.89 -82.24 -56.45 -68.98 -59.99 -54.91 -48.87 -57.28 -53.16 -53.81 -33.85 -54.72 -67.18 -59.63 -32.46 -32.75 -45.41 -38.12 -88.29 -33.53 -0.46 -54.01

ROCE %

25.34 4.85 -4.43 -19.44 -27.14 -28.97 -43.02 -47.78 -53.73 -41.49 -57.13 -58.72 -64.16 -54.05 -88.60 -107.51 -131.40 -128.27 -211.97 -247.17 -271.75 -304.94 -257.02 -223.03 -176.00 -71.32 12.51 132.12 276.14 300.32 -267.81 -919.77 -1471.31 -1386.54 -1437.11 -919.54 -550.90 -204.86 -216.60 -177.76 -140.51 -48.78 -83.26 -106.00 -96.35 -60.16 -259.26 -423.88 -967.69 -1166.70 -199.10 -556.61 -410.98

Current Ratio

1.8 1.7 1.8 1.8 1.8 1.8 1.5 1.6 1.7 2.0 1.8 1.9 1.9 1.7 1.7 1.7 1.7 1.3 1.3 1.4 1.3 1.3 1.3 1.3 1.3 1.6 1.6 1.6 1.6 0.8 0.8 0.8 0.8 1.0 1.0 1.0 1.0 1.3 1.3 1.3 1.3 3.1 3.1 3.1 3.1 2.5 2.5 2.5 2.5 1.1 1.1 1.1 1.1

DSO

42.9 - 46.1 48.0 33.7 - 44.2 59.9 85.0 - 96.9 99.5 81.3 - 117.5 155.1 74.7 - 43.8 48.3 62.9 31.3 30.0 27.3 59.5 - 74.9 104.2 85.0 - 31.6 40.9 41.7 - 45.5 64.4 39.7 - 25.6 23.4 11.2 - - 20.0 21.0 - 9.9 15.5 405.6 - - - -

DIO

374.1 - 347.8 342.2 369.6 - 448.5 497.9 473.2 - 480.7 469.6 451.1 - 627.6 551.3 364.9 - 611.7 461.5 347.7 152.5 185.4 176.1 116.4 - 102.1 265.9 4414.8 - 1401.7 1197.0 - - - - - - - - - - - - - - - - - - - - -

DPO

35.0 - 24.6 26.3 29.6 - 53.1 44.5 47.6 - 52.7 44.4 59.6 - 85.2 74.9 54.9 - 105.8 79.8 73.1 48.3 58.8 55.8 44.0 - 47.9 124.7 2122.7 - 716.1 611.5 - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

417.0 - 393.9 390.2 403.3 - 492.7 557.8 558.2 - 577.6 569.2 532.4 - 745.1 706.4 439.6 - 655.5 509.8 410.6 183.8 215.4 203.4 176.0 - 176.9 370.0 4499.9 - 1433.3 1237.9 41.7 - 45.5 64.4 39.7 - 25.6 23.4 11.2 - - 20.0 21.0 - 9.9 15.5 405.6 - - - -

Cash Conversion Cycle

382.0 - 369.4 363.9 373.7 - 439.6 513.3 510.6 - 524.9 524.8 472.8 - 659.9 631.5 384.8 - 549.8 430.0 337.5 135.5 156.7 147.6 131.9 - 129.1 245.4 2377.1 - 717.2 626.4 41.7 - 45.5 64.4 39.7 - 25.6 23.4 11.2 - - 20.0 21.0 - 9.9 15.5 405.6 - - - -

All numbers in USD currency